Raffaele Cozzolongo Selected Research

Raffaele Cozzolongo Research Topics

Disease

11	Fibrosis (Cirrhosis) 08/2023 - 02/2009
8	Non-alcoholic Fatty Liver Disease 08/2023 - 08/2017
7	Infections 09/2023 - 12/2005
6	Chronic Hepatitis C 09/2015 - 01/2002
5	Obesity 03/2024 - 01/2022
4	Insulin Resistance 03/2024 - 01/2022
4	Liver Diseases (Liver Disease) 03/2024 - 02/2023
3	Overweight 03/2024 - 02/2023
3	Weight Loss (Weight Reduction) 10/2023 - 02/2023
3	Neoplasms (Cancer) 02/2023 - 01/2008
3	Ascites 11/2022 - 01/2018
3	Biliary Liver Cirrhosis (Primary Biliary Cirrhosis) 11/2022 - 10/2019
2	Fatty Liver 03/2024 - 10/2023
2	Disease Progression 09/2023 - 05/2023
2	Persistent Infection 09/2023 - 08/2016
2	Liver Cirrhosis (Hepatic Cirrhosis) 08/2023 - 01/2018
2	Alcoholic Liver Diseases (Alcoholic Liver Disease) 01/2023 - 01/2022
2	Thrombocytopenia (Thrombopenia) 01/2022 - 07/2014
2	Hepatitis C 07/2014 - 01/2008
1	Hepatocellular Carcinoma (Hepatoma) 02/2023
1	Human Influenza (Influenza) 01/2023
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2022
1	Osteoporosis 01/2022
1	Hepatitis B 01/2022
1	Liver Failure 01/2022
1	Chronic Renal Insufficiency 10/2019
1	Substance-Related Disorders (Drug Abuse) 10/2019
1	End Stage Liver Disease 10/2018
1	Inflammation (Inflammations) 08/2017
1	Mood Disorders (Mood Disorder) 09/2015
1	Cytopenia 07/2014
1	Neutropenia 07/2014
1	Hemorrhage 07/2014
1	Chronic Hepatitis (Chronic Active Hepatitis) 01/2014
1	Virus Diseases (Viral Diseases) 01/2008
1	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 06/2006
1	Diabetes Mellitus 06/2006

Drug/Important Bio-Agent (IBA)

6	Ribavirin (Virazole)FDA LinkGeneric 08/2016 - 06/2006
6	InterferonsIBA 09/2015 - 01/2002
5	Insulin (Novolin)FDA Link 03/2024 - 06/2006
4	Triglycerides (Triacylglycerol)IBA 03/2024 - 02/2023
4	Biomarkers (Surrogate Marker)IBA 02/2023 - 01/2022
3	CholesterolIBA 03/2024 - 02/2023
3	LDL CholesterolIBA 03/2024 - 02/2023
3	Blood Glucose (Blood Sugar)IBA 03/2024 - 02/2023
3	LipidsIBA 05/2023 - 08/2017
3	AlbuminsIBA 11/2022 - 01/2018
3	Antiviral Agents (Antivirals)IBA 09/2017 - 02/2009
3	RNA (Ribonucleic Acid)IBA 08/2016 - 06/2006
2	HDL CholesterolIBA 03/2024 - 10/2023
2	Proteins (Proteins, Gene)FDA Link 05/2023 - 03/2022
2	obeticholic acidIBA 11/2022 - 04/2021
2	Ursodeoxycholic Acid (Urso)FDA LinkGeneric 04/2021 - 10/2019
1	Fetal Proteins (Fetoprotein)IBA 10/2023
1	Surface Antigens (Surface Antigen)IBA 09/2023
1	Hepatitis B e AntigensIBA 09/2023
1	Hepatitis B Surface Antigens (HBsAg)FDA Link 09/2023
1	CarbohydratesIBA 05/2023
1	PolyphenolsIBA 05/2023
1	AntioxidantsIBA 05/2023
1	FatsIBA 05/2023
1	SugarsIBA 05/2023
1	Tumor Biomarkers (Tumor Markers)IBA 02/2023
1	Thyroid HormonesIBA 02/2023
1	Vitamin D FDA LinkGeneric 02/2023
1	Influenza Vaccines (Influenza Vaccine)FDA Link 01/2023
1	BilirubinIBA 11/2022
1	Oral ContraceptivesIBA 01/2022
1	Uric Acid (Urate)IBA 01/2022
1	SuspensionsIBA 04/2021
1	Serum AlbuminIBA 01/2021
1	Alkaline PhosphataseIBA 10/2019
1	glecaprevir and pibrentasvirIBA 10/2019
1	Human Serum Albumin FDA LinkGeneric 01/2018
1	Furosemide (Lasix)FDA LinkGeneric 01/2018
1	Fatty Acids (Saturated Fatty Acids)IBA 08/2017
1	stearic acid (magnesium stearate)FDA LinkGeneric 08/2017
1	Oleic Acid (Oleate)IBA 08/2017
1	telaprevirIBA 08/2016
1	N- (3- amino- 1- (cyclobutylmethyl)- 2,3- dioxopropyl)- 3- (2- ((((1,1- dimethylethyl)amino)carbonyl)amino)- 3,3- dimethyl- 1- oxobutyl)- 6,6- dimethyl- 3- azabicyclo(3.1.0)hexan- 2- carboxamideIBA 08/2016
1	Serotonin (5 Hydroxytryptamine)IBA 09/2015
1	5-HT1A Serotonin ReceptorIBA 09/2015
1	Glycoproteins (Glycoprotein)IBA 01/2008
1	AntibodiesIBA 06/2006
1	AutoantibodiesIBA 06/2006
1	Glutamate Decarboxylase (Decarboxylase, Glutamate)IBA 06/2006

Therapy/Procedure

8	Therapeutics 10/2018 - 06/2006
3	Ketogenic Diet 03/2024 - 02/2023
3	Mediterranean Diet 08/2023 - 11/2019
2	Duration of Therapy 10/2019 - 01/2008
2	Blood Transfusion (Blood Transfusions) 11/2009 - 12/2005
1	Drug Therapy (Chemotherapy) 01/2022
1	Aftercare (After-Treatment) 09/2017